Carson Wealth (CWM LLC)
HUMA icon

Carson Wealth (CWM LLC)’s Humacyte HUMA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.4K Buy
97,873
+96,636
+7,812% +$100K ﹤0.01% 3686
2025
Q4 		$1K Sell
1,237
-13,825
-92% -$19.6K ﹤0.01% 5229
2025
Q3 		$26K Sell
15,062
-28,469
-65% -$55.8K ﹤0.01% 3964
2025
Q2 		$91K Buy
43,531
+43,386
+29,921% +$83.3K ﹤0.01% 2806
2025
Q1 		$0 Sell
145
-621
-81% -$2.33K ﹤0.01% 5119
2024
Q4 		$4K Sell
766
-2,086
-73% -$10.3K ﹤0.01% 4312
2024
Q3 		$16K Buy
2,852
+79
+3% +$521 ﹤0.01% 3509
2024
Q2 		$13K Buy
+2,773
New +$14.4K ﹤0.01% 3387
2024
Q1 		– Sell
-11
Closed – – 4499
2023
Q4 		$0 Buy
+11
New +$28 ﹤0.01% 4305

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Carson Wealth (CWM LLC)'s HUMA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Humacyte (HUMA) stake by 7,812% in Q1 2026, buying an estimated $100K and bringing the position to 97,873 shares worth $59.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3686.

Carson Wealth (CWM LLC) first reported a position in HUMA in Q4 2023 and has held it in 9 quarters since. The position peaked at $91K in Q2 2025. 159 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 97,873 shares of Humacyte worth $59.4K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 96,636 Humacyte shares in Q1 2026, an estimated $100K.
  • Humacyte made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3686 holding.
  • Carson Wealth (CWM LLC) first reported a position in Humacyte in Q4 2023 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s Humacyte position peaked at $91K in Q2 2025.
  • 159 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.